Enhanced activity of antifungal drugs by lysozyme against Cryptococcus neoformans

Mycoses

Volumn 41, Issue 5-6, 1998, Pages 199-202

  Nakamura, Y ^a   Kano, R ^a   Watanabe, S ^a   Takahashi, H ^a   Hasegawa, A ^b  

^a TEIKYO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antifungal drugs; Cryptococcus neoformans; Lysozyme; Susceptibility in vitro; Urease activity

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; LYSOZYME; TERBINAFINE;

ANTIFUNGAL ACTIVITY; ARTICLE; CRYPTOCOCCUS NEOFORMANS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

FILOBASIDIELLA NEOFORMANS;

EID: 0031870406     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.1998.tb00324.x     Document Type: Article

References (15)

1. Schaude, M., Ackerbauer, H. & Mieth, H. (1987) Inhibitory effects of antifungal agents on germ tube formation in Candida albicans. mycoses 30, 281-287.
2. Tobgi, R. S., Samaranayake, L. P. & MacFarlane, T. W. (1988) In vitro susceptibility of Candida species to lysozyme. Oral Microbiol. Immunol. 3, 35-39.
3. Anaissie, E. J., Paetznick, V. & Bodey, G. P. (1991) Fluconazole susceptibility testing of Candida albicans: microtiter method that is dependent of inoculum size, temperature and time of reading. Antimicrob. Agents Chemother 35, 1641-1646.
4. Mikami, Y., Sakamoto, T., Yazawa, K., Gonoi, T., Ueno, Y. & Hasegawa, S. (1993) Comparison of in vitro antifungal activity of itraconazole and hydroxyitraconazole by colorimetric MTT assay, mycoses 37, 27-33.
5. Nakamura, Y., Watanabe, S., Takahashi, H. & Hasegawa, A. (1998) Anti-Candida activity of lysozyme. Bull. Soc. Franco-Japonaise Sci. Vet. 8, 8-16.
6. Collins, M. S. & Pappagianis, D. (1974) Lysozyme-enhanced killing of Candida albicans and Coccidioides immitis by amphotericin B. Sabouraudia 12, 329-340.
7. Tansho, S., Tansho, T., Ikeda, T., Perera, P. D., Abe, S. & Yamaguchi, H. (1996) Augmentation of anti-Candida activity of lanoconazole by lysozyme. Jpn J. Med. Mycol 37, 245-249.
8. Espinel-Ingroff, A., Kish, JR. C. W., Kerkering, T. M., et al. (1992) Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin Microbiol 30, 3138-3145.
9. Nakamura, Y., Kano, R., Watanabe, S., Takahashi, H. & Hasegawa, A. (1998) Susceptibility testing of Cryptococcus neoformans by urea broth microdilution method. mycoses 41, 41-44.
10. Pal, M., Onda, C. & Hasegawa, A. (1991) Sexual compatibility of clinical and environmental isolates of Cryptococcus neoformans. Jpn J. Med. Mycol. 32, 101-106.
11. Marquis, G., Montplaisir, S., Garzon, S., Strykowski, H. & Auger, P. (1982) Fungitoxicity of muramidase. Ultrastructural damage to Candida albicans. Lab. Invest. 46, 627-636.
12. Marquis, G., Garzon, S., Strykowski, H., Auger, P. & Benhamou, N. (1993) Muramidase-mediated damage to Candida yeast cells. Histochemical and immunochemical characterization of accumulating wall-like material. J. Submicrosc. Cytol. Pathol. 25, 347-355.
13. Marquis, G., Garzon, S., Strykowski, H. & Auger, P. (1991) Cell walls of normal and lysozyme-damaged blastoconidia of Candida albicans: localization of surface factor 4 antigen and vicinal-glycol staining. Infect. Immun. 59, 1312-1318.
14. Goldberg, S., Doyle, R. J. & Rosenberg, M. (1990) Mechanism of enhancement of microbial cell hydrophobicity by cationic polymers. J. Bacteriol. 172, 5630-5654.
15. Igarashi, K. & Matsuyama, T. (1990) Alternative activity of beta-lactam antibiotics Methicillin- and Cephem-resistant Staphylococcus aureus in the presence of respiratory tract mucus. J. Infect. Dis. 161, 250-254.